Cancer consistently presents a pressing global health concern. Consequently, the pursuit of innovative approaches for its early diagnosis and effective treatment remains an area of intense research focus. Notably, biomolecule or cell-based nanosystems have emerged as promising tools for the precise detection of cancer, targeted drug delivery, and innovative therapeutics.
This Research Topic endeavors to explore the latest advancements in nanosystems, specifically designed for cancer diagnosis and therapeutic interventions. Our objective is to gather experts from diverse academic disciplines to share their research findings and insights regarding the burgeoning advancements in biomolecule or cell-based nanosystems applied in cancer treatments. We encourage contributions that shed light on various aspects, including the design, synthesis, characterization, and application of nanosystems in the scope of cancer diagnosis and therapy.
Potential areas of interest for this Research Topic could include, but are not confined to:
• The development of novel strategies for biomolecule-based nanosystems applied in cancer imaging and diagnostics.
• The use of cell-based nanosystems for targeted drug delivery and controlled release in cancer therapy.
• Bioconjugation techniques employed for the functionalization of biomolecules within nanosystems, enhancing cancer-specific targeting.
• Hybrid nanosystems that integrate both biomolecules and nanoparticles, enabling multimodal cancer imaging and therapy.
• Biocompatibility and toxicity assessment of biomolecule or cell-based nanosystems (for safe clinical translation).
Keywords:
Biomolecule-based nanosystems, Cell-based nanosystems, Cancer diagnosis, Therapeutic interventions
Important Note:
All contributions to this Research Topic must be within the scope of the section and journal to which they are submitted, as defined in their mission statements. Frontiers reserves the right to guide an out-of-scope manuscript to a more suitable section or journal at any stage of peer review.
Cancer consistently presents a pressing global health concern. Consequently, the pursuit of innovative approaches for its early diagnosis and effective treatment remains an area of intense research focus. Notably, biomolecule or cell-based nanosystems have emerged as promising tools for the precise detection of cancer, targeted drug delivery, and innovative therapeutics.
This Research Topic endeavors to explore the latest advancements in nanosystems, specifically designed for cancer diagnosis and therapeutic interventions. Our objective is to gather experts from diverse academic disciplines to share their research findings and insights regarding the burgeoning advancements in biomolecule or cell-based nanosystems applied in cancer treatments. We encourage contributions that shed light on various aspects, including the design, synthesis, characterization, and application of nanosystems in the scope of cancer diagnosis and therapy.
Potential areas of interest for this Research Topic could include, but are not confined to:
• The development of novel strategies for biomolecule-based nanosystems applied in cancer imaging and diagnostics.
• The use of cell-based nanosystems for targeted drug delivery and controlled release in cancer therapy.
• Bioconjugation techniques employed for the functionalization of biomolecules within nanosystems, enhancing cancer-specific targeting.
• Hybrid nanosystems that integrate both biomolecules and nanoparticles, enabling multimodal cancer imaging and therapy.
• Biocompatibility and toxicity assessment of biomolecule or cell-based nanosystems (for safe clinical translation).
Keywords:
Biomolecule-based nanosystems, Cell-based nanosystems, Cancer diagnosis, Therapeutic interventions
Important Note:
All contributions to this Research Topic must be within the scope of the section and journal to which they are submitted, as defined in their mission statements. Frontiers reserves the right to guide an out-of-scope manuscript to a more suitable section or journal at any stage of peer review.